Conghui Han

Targeting HNRNPU to overcome cisplatin resistance in bladder cancer

Zhenduo Shi, Lin Hao, Xiaoxiao Han et al. · Molecular Cancer · 2022 · 128 citations · Full text

Medicine, Molecular Biology, Oncology +17

Lipopolysaccharide-induced cross-tolerance against renal ischemia–reperfusion injury is mediated by hypoxia-inducible factor-2α-regulated nitric oxide production

Kang He, Xiaosong Chen, Conghui Han et al. · Kidney International · 2013 · 58 citations

Medicine, Immunology, Nephrology +16

Role of NRP1 in Bladder Cancer Pathogenesis and Progression

Yang Dong, Weiming Ma, Zhenduo Shi et al. · Frontiers in Oncology · 2021 · 48 citations · Full text

Medicine, Molecular Biology, Oncology +15

Simulated microgravity suppresses MAPK pathway‐mediated innate immune response to bacterial infection and induces gut microbiota dysbiosis

Jing Wang, Conghui Han, Zhe Lü et al. · The FASEB Journal · 2020 · 45 citations

Life Sciences, Immunology, Microbiology +17

A network pharmacology perspective for deciphering potential mechanisms of action of Solanum nigrum L. in bladder cancer

Yang Dong, Lin Hao, Kun Fang et al. · BMC Complementary Medicine and Therapies · 2021 · 38 citations · Full text

Life Sciences, Oncology, Pharmacology +17